Improved Differential Diagnosis of Alzheimer’s Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers
Payam Emami Khoonsari(Stockholm University), Kim Kultima(Uppsala University), Lars Lannfelt(BioArctic Neuroscience (Sweden)), Vilmantas Giedraitis(Uppsala University), Ganna Shevchenko(Uppsala University), Henrik Zetterberg(University of Wisconsin–Madison), Stephanie Herman(Uppsala University), Peter Nilsson(Science for Life Laboratory), Lena Kilander(British Geriatrics Society), Malin Degerman Gunnarsson(Uppsala University), Martin Ingelsson(Uppsala University), RoseMarie Brundin(Uppsala University), Julia Remnestål(Science for Life Laboratory)
Cited by 69
Related Papers
New insights into the genetic etiology of Alzheimer’s disease and related dementias
|Nature Genetics|2022|2.5k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k
Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure
|Nature Communications|2020|936